These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24992675)

  • 1. BAG3 upregulates Mcl-1 through downregulation of miR-29b to induce anticancer drug resistance in ovarian cancer.
    Sugio A; Iwasaki M; Habata S; Mariya T; Suzuki M; Osogami H; Tamate M; Tanaka R; Saito T
    Gynecol Oncol; 2014 Sep; 134(3):615-23. PubMed ID: 24992675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BAG3-mediated Mcl-1 stabilization contributes to drug resistance via interaction with USP9X in ovarian cancer.
    Habata S; Iwasaki M; Sugio A; Suzuki M; Tamate M; Satohisa S; Tanaka R; Saito T
    Int J Oncol; 2016 Jul; 49(1):402-10. PubMed ID: 27120977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer.
    Huh JH; Kim TH; Kim K; Song JA; Jung YJ; Jeong JY; Lee MJ; Kim YK; Lee DH; An HJ
    Br J Cancer; 2013 Jul; 109(2):452-61. PubMed ID: 23807165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAG3 increases the invasiveness of uterine corpus carcinoma cells by suppressing miR-29b and enhancing MMP2 expression.
    Habata S; Iwasaki M; Sugio A; Suzuki M; Tamate M; Satohisa S; Tanaka R; Saito T
    Oncol Rep; 2015 May; 33(5):2613-21. PubMed ID: 25738313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of miR-29b signaling in the sensitivity to chemotherapy in patients with ovarian carcinoma.
    Dai F; Zhang Y; Chen Y
    Hum Pathol; 2014 Jun; 45(6):1285-93. PubMed ID: 24767251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-340 induces apoptosis by downregulation of BAG3 in ovarian cancer SKOV3 cells.
    Qu F; Wang X
    Pharmazie; 2017 Aug; 72(8):482-486. PubMed ID: 29441908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-143 enhances the antitumor activity of shikonin by targeting BAG3 expression in human glioblastoma stem cells.
    Liu J; Qu CB; Xue YX; Li Z; Wang P; Liu YH
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):105-12. PubMed ID: 26541455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3.
    Jeong JY; Kang H; Kim TH; Kim G; Heo JH; Kwon AY; Kim S; Jung SG; An HJ
    Cancer Lett; 2017 Feb; 386():168-178. PubMed ID: 27887917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-κB1, c-Rel, and ELK1 inhibit miR-134 expression leading to TAB1 upregulation in paclitaxel-resistant human ovarian cancer.
    Shuang T; Wang M; Zhou Y; Shi C; Wang D
    Oncotarget; 2017 Apr; 8(15):24853-24868. PubMed ID: 28206956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA hsa-miR-29b potentiates etoposide toxicity in HeLa cells via down-regulation of Mcl-1.
    Kollinerová S; Dostál Z; Modrianský M
    Toxicol In Vitro; 2017 Apr; 40():289-296. PubMed ID: 28185889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulated expression of miR-134 contributes to paclitaxel resistance in human ovarian cancer cells.
    Shuang T; Wang M; Shi C; Zhou Y; Wang D
    FEBS Lett; 2015 Oct; 589(20 Pt B):3154-64. PubMed ID: 26363097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction.
    Gigante M; Pontrelli P; Herr W; Gigante M; D'Avenia M; Zaza G; Cavalcanti E; Accetturo M; Lucarelli G; Carrieri G; Battaglia M; Storkus WJ; Gesualdo L; Ranieri E
    J Transl Med; 2016 Apr; 14():84. PubMed ID: 27063186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells.
    Miyamoto M; Sawada K; Nakamura K; Yoshimura A; Ishida K; Kobayashi M; Shimizu A; Yamamoto M; Kodama M; Hashimoto K; Kimura T
    Sci Rep; 2020 Oct; 10(1):16755. PubMed ID: 33028939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAG3 promotes proliferation of ovarian cancer cells via post-transcriptional regulation of Skp2 expression.
    Yan J; Liu C; Jiang JY; Liu H; Li C; Li XY; Yuan Y; Zong ZH; Wang HQ
    Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1668-1678. PubMed ID: 28624440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation.
    Drago-Ferrante R; Pentimalli F; Carlisi D; De Blasio A; Saliba C; Baldacchino S; Degaetano J; Debono J; Caruana-Dingli G; Grech G; Scerri C; Tesoriere G; Giordano A; Vento R; Di Fiore R
    Oncotarget; 2017 Apr; 8(17):28939-28958. PubMed ID: 28423652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and clinical role of chemoresponse-associated genes in ovarian serous carcinoma.
    Nymoen DA; Hetland Falkenthal TE; Holth A; Ow GS; Ivshina AV; Tropé CG; Kuznetsov VA; Staff AC; Davidson B
    Gynecol Oncol; 2015 Oct; 139(1):30-9. PubMed ID: 26232338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
    Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
    Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA LINC00152 promotes cell proliferation through competitively binding endogenous miR-125b with MCL-1 by regulating mitochondrial apoptosis pathways in ovarian cancer.
    Chen P; Fang X; Xia B; Zhao Y; Li Q; Wu X
    Cancer Med; 2018 Sep; 7(9):4530-4541. PubMed ID: 30030896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation-associated Has-miR-9 deregulation in paclitaxel- resistant epithelial ovarian carcinoma.
    Li X; Pan Q; Wan X; Mao Y; Lu W; Xie X; Cheng X
    BMC Cancer; 2015 Jul; 15():509. PubMed ID: 26152689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UCA1 confers paclitaxel resistance to ovarian cancer through miR-129/ABCB1 axis.
    Wang J; Ye C; Liu J; Hu Y
    Biochem Biophys Res Commun; 2018 Jul; 501(4):1034-1040. PubMed ID: 29777711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.